Use of Aptar Digital Health's Respiratory Disease Management Platform for Asthma: A Pilot Study
The United Kingdom has a high prevalence of asthma (over 12%) and some of the worst health outcomes in Europe. The management of respiratory disease and associated patient outcomes has long been an area of focus and improvement for the National Health Service. With the advancement of digital health technology, there is the potential to transform patient care and improve outcomes. The Aptar Digital Health respiratory disease management platform, a digital therapeutic will be utilized to determine its value and how it supports: i) asthma patient engagement and facilitates communication between patients and providers to accelerate medication adherence; ii) asthma control through the use of the Asthma Control Questionnaire-5. In addition, spirometry and fractioned exhaled nitric oxide will be utilized during the study to validate and enhance current National Institute for Health and Care Excellence guidelines.
• Age ≥ 16 years
• Utilization of asthma controller therapy: inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and/or fixed combination therapies of LABA and ICS (medium to high-dose ICS/LABA therapy)
• Use of metered dose inhaler (MDI) and / or dry powder dose inhaler (DPI) list of compatible medications is noted in section 9.2.
• FeNO ≥ 45 ppb
• Primary respiratory diagnosis of asthma
• Patients with uncontrolled, moderate-to-severe asthma
• Non-smoker
• Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in consent form and protocol.
• Subject understands and is willing, able, and likely to comply with study procedures and restrictions
• Willingness to participate in this study and to use the Aptar Digital Health technology
• Willingness to share information / data with Aptar Digital Health (through informed consent)
⁃ Access to technology
• Access to a smartphone (requirements Android ≥13 and iOS ≥16
• Ability to use smartphone (smartphone usability assessment to be provided by Aptar Digital Health)
• Access to a current email account
• Access to data / Wi-Fi